Intrinsiqq
Pharma Equity Group A/S logo

Pharma Equity Group A/S Quality Score

PEG.XCSE

Compare
Quality0

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
0/100
34.4%

Heavy dilution above 5%

Capital Structure
0/100
kr 3M

Positive debt with no FCF to service it

2022
kr 182000
kr 23.0M
2023
kr 4.00M
kr 30.0M
2024
kr 4.00M
kr 3.00M
2025
kr 498000
kr 4.00M
CashDebt
Return on Capital
0/100
-41.8%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Peers

Biotechnology · Pick stocks to compare with PEG.XCSE

CompareIntrinsic value
BIOPOR.XCSEBioPorto A/S
€0.11-4.31%36
VIRO.XCSEViroGates A/S
€0.80-13.11%10
STENO.XCSEStenocare A/S
€0.07-3.34%30
GUBRA.XCSEGubra A/S
€34.90-2.73%98
BAVA.XCSEBavarian Nordic A/S
€33.58+2.88%84
GN.XCSEGN Store Nord A/S
No recent price3
DEMANT.XCSEDemant A/S
kr 344.10-1.83%71
NEWBRY.XSTONewbury Pharmaceuticals AB
€0.11+0.91%40

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PEG.XCSE

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.